SCHEMBL25684093

SCHEMBL25684093

Cc1cnc(COC(=O)N(C)C)nc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 4/20 0.37
▸ CHRNA4 P43681 4/20 0.37
▸ CHRM2 P08172 3/20 0.37
▸ CHRM4 P08173 3/20 0.37
▸ CHRM5 P08912 3/20 0.37
▸ CHRM1 P11229 3/20 0.37
▸ CHRM3 P20309 3/20 0.37
▸ RAB9A P51151 1/20 0.34
▸ CHRNB4 P30926 1/20 0.33
▸ CHRNA3 P32297 1/20 0.33
▸ APLNR P35414 1/20 0.32
▸ FOS P01100 1/20 0.32
▸ JUN P05412 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25680855 0.81 CHRNB2 (0.38) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL18611841 0.78 RAB9A (0.38) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL25680862 0.72 GABRA1 (0.36) CHRM1RAB9AAPLNRKDM4E
SCHEMBL11707907 0.71 L3MBTL1 (0.42) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL11131589 0.70 MMP2 (0.49) RAB9AKDM4E
Hydrochloric Acid SCHEMBL11711882 0.70 L3MBTL1 (0.41) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL7694634 0.69 PRSS1 (0.47) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL12457547 0.68 LMNA (0.44) RAB9AAPLNRKDM4E
SCHEMBL25680845 0.67 SMN1; SMN2 (0.50) KDM4E
SCHEMBL12527635 0.67 ALOX5 (0.38) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137329-A1 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2024-06-27 — — WO disclosed
WO-2023114198-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 — — WO disclosed
WO-2023114200-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 — — WO disclosed
Send feedback